Home > Income Statement > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Total Expenditure

    Back to Income Statement
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Total Expenditure History

[Consolidated]

Mar2024Mar2023Mar2022Mar2013Mar2012
Total Expenditure ₹252 Cr₹241 Cr₹11,780,424 Cr₹109 Cr₹109 Cr

What is the latest Total Expenditure of NATH BIOGENES (INDIA) ?

The latest Total Expenditure ratio of NATH BIOGENES (INDIA) is ₹252 Cr based on Mar2024 Consolidated results.
Year Total Expenditure
Mar2024₹252 Cr
Mar2023₹241 Cr
Mar2022₹11,780,424 Cr
Mar2013₹109 Cr
Mar2012₹109 Cr

How is Total Expenditure of NATH BIOGENES (INDIA) Trending?

Years Total Expenditure % Change
Mar2024 ₹252 Cr
4.66
Mar2023 ₹241 Cr
-100.00
Mar2022 ₹11,780,424 Cr
10,783,686.36
Mar2013 ₹109 Cr
0.00
Mar2012 ₹109 Cr -

Compare Total Expenditure of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹390.5 Cr 1.5% 9.3% -0.2% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹13,503.0 Cr -2.5% 0.1% 17.5% Stock Analytics
KAVERI SEED COMPANY ₹6,611.0 Cr -7.2% -2.8% 41% Stock Analytics
VENKYS (INDIA) ₹2,276.8 Cr -1.3% -0.5% -13.1% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,437.8 Cr -0.8% -2.7% -29.7% Stock Analytics
INDO US BIOTECH ₹316.3 Cr -10.2% -0.5% -28% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

1.5%

9.3%

-0.2%

SENSEX

-1.3%

-0.8%

6.3%


You may also like the below Video Courses